GX-188E
Showing 1 - 25 of 3,323
Head and Neck Squamous Cell Carcinoma Trial in Seoul (GX-188E+GX-I7+Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 18, 2022
Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Apr 20, 2022
Chronic Disease Trial in San Diego (Physical activity, Cancer screening)
Completed
- Chronic Disease
- Physical activity
- Cancer screening
-
San Diego, CaliforniaSan Diego State University Research Foundation
Sep 27, 2021
Prostate Cancer Trial in Italy, Spain (GX301)
Completed
- Prostate Cancer
- GX301
-
Alessandria, Italy
- +23 more
Jul 21, 2020
Sweat Analysis Trial in Walnut Creek (Gx sweat patch, Reference sweat patch)
Completed
- Sweat Analysis
- Gx sweat patch
- Reference sweat patch
-
Walnut Creek, CaliforniaNBA G League Ignite Team Site Ultimate Fieldhouse, 2675 Mitchell
Jun 22, 2022
Glioblastoma, High Grade Glioma, Recurrent Glioblastoma Trial in Seoul (GX-I7)
No longer available
- Glioblastoma
- +4 more
-
Seoul, Korea, Republic ofKangnam St. Mary's Hospital
Mar 2, 2022
SARS-CoV2 Infection Trial (GX-19N, Placebo)
Withdrawn
- SARS-CoV2 Infection
- GX-19N
- Placebo
- (no location specified)
Apr 4, 2022
Recurrent Glioblastoma Trial in Seoul (GX-I7, Bevacizumab)
Recruiting
- Recurrent Glioblastoma
-
Seoul, Korea, Republic ofSeoul St.Mary's Hospital of the Catholic University of Korea
Jan 3, 2022
Newly Diagnosed Glioblastoma Trial in Suwon-si (GX-I7, Placebo)
Withdrawn
- Newly Diagnosed Glioblastoma
- GX-I7
- Placebo
-
Suwon-si, Korea, Republic ofSt. Vincent Hospital
Mar 2, 2022
Total Thyroidectomy, Near-total Thyroidectomy Trial in Busan, Seoul, Suwon (Period 1 GX-30, Period 2 THYROGEN®, Period 1
Completed
- Total Thyroidectomy
- Near-total Thyroidectomy
- Period 1 GX-30, Period 2 THYROGEN®
- Period 1 THYROGEN®, Period 2 GX-30
-
Busan, Korea, Republic of
- +4 more
Sep 7, 2020
Autoimmune Diseases Trial in Seoul (GX-P1 or Placebo (dose level 1), GX-P1 or Placebo (dose level 2), GX-P1 or Placebo (dose
Completed
- Autoimmune Diseases
- GX-P1 or Placebo (dose level 1)
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Jul 21, 2021
GX-188E DNA Therapeutic Vaccine Administered by Electroporation
Unknown status
- Cervical Intraepithelial Neoplasia 3
- GX-188E
-
Seoul, Korea, Korea, Republic ofCheil General Hospital & Women's Healthcare Center
Jul 11, 2017
Cervical Intraepithelial Neoplasia 3 Trial in Seoul (GX-188E, GX-I7, GX-188E, Imiquimod)
Unknown status
- Cervical Intraepithelial Neoplasia 3
- GX-188E, GX-I7
- GX-188E, Imiquimod
-
Seoul, Korea, Republic ofSeoul St. Mary's hospital
Jun 29, 2017
GX-188E DNA Therapeutic Vaccine Administered by Electroporation
Unknown status
- Cervical Intraepithelial Neoplasia 3
- GX-188E
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Jul 11, 2017
MEDICATION RELATED OSTEONECROSIS OF THE JAW Trial in Palermo (OxigenOzone_Insufflation)
Completed
- MEDICATION RELATED OSTEONECROSIS OF THE JAW
- OxigenOzone_Insufflation
-
Palermo, ItalyAzienda Ospedaliera Universitaria Policlinico "P. Giaccone" Pale
Oct 4, 2023
Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis
Recruiting
- Dermatomyositis
- +2 more
-
Zhejiang, Hangzhou, ChinaThe Third People's Hospital of Hangzhou
Aug 21, 2023
Cervical Intraepithelial Neoplasia Trial in Daegu, Seoul (GX-188E)
Completed
- Cervical Intraepithelial Neoplasia
- GX-188E
-
Daegu, Korea, Republic of
- +3 more
Jul 11, 2017
GLP-1, Gut Microbiota Trial in Mexico City (sucralose, )
Recruiting
- GLP-1
- Gut Microbiota
- sucralose
- placebo
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Oct 17, 2023
Bone Density, Body Composition, Bone Health Trial in Boston (Vitamin D3 , Fish oil , omega-3 fatty acids (fish oil))
Active, not recruiting
- Bone Density
- +2 more
- Vitamin D3 placebo
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 12, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Avelumab, Chemoradiation)
Terminated
- Squamous Cell Carcinoma of the Head and Neck
- Avelumab
- Chemoradiation
-
Fayetteville, Arkansas
- +315 more
Sep 20, 2021